Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A Japanese journalist was ordered to pay ¥3.3 million to an anti-vaccine researcher, this week, after a court found her …
News

Working Life: Dr Paul-Peter Tak, ex-Senior Vice President, Development Lead and Chief Immunology Officer at GSK, Venture Partner at Flagship Pioneering

March 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Working Life, feature

Dr Paul-Peter Tak, ex-Senior Vice President, Development Lead and Chief Immunology Officer at GSK, Venture Partner at Flagship Pioneering.How did …
Feature
eye2

J&J’s antihistamine-releasing contact lens shows promise in Phase 3 trials

March 28, 2019 Research and Development J&J, JJ, eye care, pharma

Johnson and Johnson has unveiled new Phase 3 data on its antihistamine-releasing contact lens, showing that the investigational product led …
News

AMR advisor calls for public utility company to tackle AMR

March 28, 2019 Medical Communications, Research and Development AMR, Lord Jim O'Neill, antimicrobial resistance, pharma, public health

Lord Jim O’Neill, an economist and former government advisor on antimicrobial resistance (AMR), has accused the pharmaceutical industry of “spewing …
News

Japanese court orders public health campaigner to pay ¥3.3 million to anti-vaccine researcher

March 27, 2019 Medical Communications, Research and Development HPV, Japan, anti vaxx, anti-vaccine, public health, vaccines

Dr Riko Muranaka, a researcher and journalist who has campaigned against misinformation surrounding vaccines, has been ordered to pay ¥3.3 …
News
vaccination_2

Measles outbreak spurs New York County to ban all unvaccinated children from public spaces

March 27, 2019 Research and Development New York, US, pharma, vaccination, vaccines

Rockland County, New York State, is taking serious measures to combat its biggest measles outbreak in decades, making the decision …
News
abbvie_0

Japan awards AbbVie’s Skyrizi with first approval, in 4 psoriasis indications

March 27, 2019 Research and Development, Sales and Marketing AbbVie, Japan, Skyrizi, pharma, psoriasis

AbbVie has announced that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has been awarded approval in Japan from the nation’s Ministry …
News

Children with high adherence to ADHD medication methylphenidate at greater risk of being prescribed antidepressants

March 27, 2019 Research and Development ADHA, mental health, methylphenidate, mph, psychiatric disorders

Children who were treated with methylphenidate-based medications (i.e. Ritalin) for conditions such as ADHD were at significantly greater risk of …
News
novartis_side_building

Novartis’ new MS drug to cost $88,000 a year

March 27, 2019 Research and Development, Sales and Marketing FDA, MS, Novartis, Novartis pharmaceuticals, multiple sclerosis

Paul Hudson, the CEO of Swiss firm Novartis Pharmaceuticals has said the company’s newly approved multiple sclerosis (MS) drug will …
News
920x920

Purdue Pharma settle Oklahoma lawsuit for $270 million

March 26, 2019 Research and Development Oklahoma, OxyContin, Purdue Pharma, opioid crisis, oxycodone

OxyContin drugmaker Purdue Pharma has agreed to pay nearly $270 million to the state of Oklahoma, in order to settle …
News
novo_nordisk_flag

Novo Nordisk’s oral semaglutide outclasses Januvia with new data in type 2 diabetes

March 26, 2019 Manufacturing and Production, Research and Development Novo Nordisk, Ozempic, diabetes, pharma, type 2 diabetes

Novo Nordisk has revealed new dose-specific Phase 3a data for its glucagon-like peptide-1 (GLP-1) analogue oral semaglutide, indicating that the …
News
peanuts02-lg

Aimmune’s peanut allergy therapy closes in on approval with promising Phase 3 data

March 26, 2019 Manufacturing and Production, Research and Development AR101, Aimmune, allergy, pharma

Aimmune Therapeutics is gearing up for regulatory review of its investigational food allergy therapy AR101 following the release of new …
News
screen_shot_2019-02-19_at_14

Conducting internal investigations within a pharmaceutical business

March 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Reed Smith, feature, internal investigations, pharma

Though often necessary, internal investigations are seldom smooth or easy. Rosanne Kay, Partner at law firm Reed Smith, outlines a …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Biogen, Eisai, FDA, Merck, NICE, Pfizer, Roche, Sandoz

This week was a bad week for clinical trials. While the FDA put Roche and AbbVie’s multiple myeloma trial on …
News

Breathing life into COPD research

March 21, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COPD, GSK, feature

Alison Hollands, Vice President, Respiratory, UK Pharmaceuticals at GlaxoSmithKline, addresses the importance of implementing the latest approaches to treating COPD …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025